Dr. Thomas Prevot is a Project Scientist, and Project Lead of the Drug Development Program within the Neurobiology of Depression and Aging Department of CAMH. Dr. Prevot received his PhD in Behavioral Neuropsychopharmacology from the University of Bordeaux in France in 2015, and did his postdoctoral fellowship in CAMH from 2016 to 2019. He is also an alumni of the EUREKA Institute for Translational Medicine.
Dr. Prevot’s research focuses on the neurobiology of stress, aging, and their interactions, and on understanding how stress and aging impact quality of life and lead to psychiatric and neurodegenerative diseases. He is the program manager of a drug development program working with Dr. Etienne Sibille. As an ethologist and a behavioural pharmacologist, he has developed unique expertise in the field of translational research, including the characterization of novel targets for therapeutic avenues and medication development for future clinical testing. Dr. Prevot is actively involved in the translational research and medicine landscape at the University of Toronto, working across disciplines and being an advocate for bench-to-bedside discovery.
Dr. Prevot also has a keen interest at improving animal welfare in laboratory settings and developed handling techniques to reduce stress in mice.
